Docturnal Raises funding from Mumbai Angels Network

Mumbai, September 25, 2018: Docturnal,a company focused on non-invasive screening solutions for Tuberculosis, raises  funding from Mumbai Angels Network(MA Network), India’s leading early stage investment platform. The Hyderabad based startup was founded in 2016, by Rahul Pathri, Balakrishna Bagadi, Arpita Singh & Vaishnavi Reddy. Docturnal screens & detects Tuberculosis using their flagship product "TimBre" using aural/acoustic inputs (cough), clinical and demographic variables. The solution uses a third party Microphone Array & is extensible to screen other Lung based ailments such as Asthma, COPD & others that have cough as a symptomatic condition. “ On the fundraise, Rahul Pathri, Founder of Docturnal said "We are excited to partner with MA Network in our journey for building a solution that is looking to revolutionize how Tuberculosis is screened and detected in the country. With the funding we looking to build the team, technology and deploy the product for clinical trials across several hospitals in the country.” 11 Investors from the MA Network are investing in the company including Akshay Mittal, Abhijeet Birewar and Shantanu Agarwal. "Non-invasive, real-time, and cost-effective diagnostic solutions will do a great deal to improve the health of our population, specially for widespread diseases with expensive solutions, leading to the risk of going undiagnosed. The first step is most important, of providing screening access to health providers. Docturnal has built a great and innovative product and we are very happy to join Rahul in this journey. We hope to help build a cutting-edge, artificial intelligence, machine learning based, medical diagnostic company that helps both patients and health-providers across the world." said Akshay Mittal, Deal Lead, MA Network. "We are excited to welcome Docturnal to our portfolio. The medtech and healthtech startup scene is buzzing and we are looking forward to investing in other innovations within the sector.We see increased interest from the next level investors, both VC Funds and the next level strategic players in companies innovating in the medical and healthcare space using technology." said MA Network CEO Nandini Mansinghka.